Related references
Note: Only part of the references are listed.Cell-Specific Delivery of Diverse Cargos by Bacteriophage MS2 Virus-like Particles
Carlee E. Ashley et al.
ACS NANO (2011)
A new RNA vaccine platform based on MS2 virus-like particles produced in Saccharomyces cerevisiae
Shipeng Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Developing therapeutic microRNAs for cancer
A. G. Bader et al.
GENE THERAPY (2011)
miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice
Mark P. Boldin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Current prospects for RNA interference-based therapies
Beverly L. Davidson et al.
NATURE REVIEWS GENETICS (2011)
Analysis of microRNA turnover in mammalian cells following Dicer1 ablation
Michael P. Gantier et al.
NUCLEIC ACIDS RESEARCH (2011)
Delivery of siRNA Therapeutics: Barriers and Carriers
Jie Wang et al.
AAPS JOURNAL (2010)
Quantitative analysis of conditional gene inactivation using rationally designed, tetracycline-controlled miRNAs
Stefan M. Berger et al.
NUCLEIC ACIDS RESEARCH (2010)
MicroRNA-146a and Human Disease
L. Li et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2010)
MicroRNA-146a Contributes to Abnormal Activation of the Type I Interferon Pathway in Human Lupus by Targeting the Key Signaling Proteins
Yuanjia Tang et al.
ARTHRITIS AND RHEUMATISM (2009)
Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell penetrating peptide
Baojun Wei et al.
BIOMEDICINE & PHARMACOTHERAPY (2009)
miR-146a Is Critical for Endotoxin-induced Tolerance IMPLICATION IN INNATE IMMUNITY
Md A. Nahid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Armored Long RNA Controls or Standards for Branched DNA Assay for Detection of Human Immunodeficiency Virus Type 1
Sien Zhan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Real-time PCR quantification of precursor and mature microRNA
Thomas D. Schmittgen et al.
METHODS (2008)
In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery
Masahiro Sakagami
ADVANCED DRUG DELIVERY REVIEWS (2006)
LNA-modified oligonucleotides mediate specific inhibition of microRNA function
Ulf Andersson Orom et al.
GENE (2006)
Cytoplasmic transduction peptide (CTP): New approach for the delivery of biomolecules into cytoplasm in vitro and in vivo
D Kim et al.
EXPERIMENTAL CELL RESEARCH (2006)
Short RNAs repress translation after initiation in mammalian cells
CP Petersen et al.
MOLECULAR CELL (2006)
Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation
S Bagga et al.
CELL (2005)
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery
CN Landen et al.
CANCER RESEARCH (2005)
A microRNA polycistron as a potential human oncogene
L He et al.
NATURE (2005)
Delivery of antisense oligonucleotides to leukemia cells by RNA bacteriophage capsids
Min Wu et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2005)
Real-time quantification of microRNAs by stem-loop RT-PCR
CF Chen et al.
NUCLEIC ACIDS RESEARCH (2005)
Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells
YL Chiu et al.
CHEMISTRY & BIOLOGY (2004)
RNA bacteriophage capsid-mediated drug delivery and epitope presentation
WL Brown et al.
INTERVIROLOGY (2002)
Both natural and designed micro RNAs technique can inhibit the expression of cognate mRNAs when expressed in human cells
Y Zeng et al.
MOLECULAR CELL (2002)
An extensive class of small RNAs in Caenorhabditis elegans
RC Lee et al.
SCIENCE (2001)
Share Paper
